4.8 Article

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Related references

Note: Only part of the references are listed.
Editorial Material Immunology

Blimp-1's Maiden Flight

Kathryn Calame

JOURNAL OF IMMUNOLOGY (2010)

Article Oncology

Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study

Debra L. Friedman et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Multidisciplinary Sciences

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim et al.

NATURE (2010)

Article Multidisciplinary Sciences

A map of human genome variation from population-scale sequencing

David Altshuler et al.

NATURE (2010)

Review Genetics & Heredity

Gene-environment-wide association studies: emerging approaches

Duncan Thomas

NATURE REVIEWS GENETICS (2010)

Article Genetics & Heredity

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk

Soumya Raychaudhuri et al.

NATURE GENETICS (2009)

Article Oncology

Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose

Louis S. Constine et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Genetics & Heredity

Principal components analysis corrects for stratification in genome-wide association studies

Alkes L. Price et al.

NATURE GENETICS (2006)

Article Medicine, General & Internal

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease

LB Travis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Oncology

Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study

JP Neglia et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)